Orchid Pharma`s arm gets nod to manufacture product `7 ACA` with committed capacity
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Orchid Pharma’s wholly owned subsidiary in India namely ‘Orchid Bio-Pharma’ has received approval to manufacture the product ‘7 ACA’ with a committed capacity of 1000 Metric Tonne Per Annum. This approval will help the Company in backward integration, reduce dependency on sourcing from China and aid in improving margins.
Orchid Pharma, established as an export-oriented unit (EOU), is a vertically integrated company spanning the entire pharmaceutical value chain from discovery to delivery with established credentials in research, manufacturing and marketing.
